Orthofix Medical (OFIX) Net Equity Issued and Repurchased (2010 - 2025)

Orthofix Medical (OFIX) has 16 years of Net Equity Issued and Repurchased data on file, last reported at $2.8 million in Q4 2025.

• Quarterly Net Equity Issued and Repurchased fell 3.63% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (up 1.94% YoY) and the FY2025 annual result came in at $5.9 million, down 5.24% from the prior year.
• Net Equity Issued and Repurchased rose to $2.8 million in Q4 2025, from $36000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.0 million in Q2 2025 to a low of $36000.0 in Q3 2025.
• A 5-year average of $1.9 million and a median of $2.3 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 81.12% — and 2025, when it sank 70.0%.
• Tracing OFIX's Net Equity Issued and Repurchased over 5 years: stood at $2.6 million in 2021, then dropped by 25.1% to $1.9 million in 2022, then surged by 41.97% to $2.8 million in 2023, then increased by 7.13% to $2.9 million in 2024, then decreased by 3.63% to $2.8 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $2.8 million (Q4 2025), $36000.0 (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.